An investment case analysis for the prevention and treatment of adolescent mental disorders and suicide in England

Angela Jackson-Morris*, Christina L. Meyer, Antony Morgan, Rachel Stelmach, Leah Jamison, Candace Currie

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Downloads (Pure)

Abstract

Background
Adolescent mental health (AMH) needs in England have increased dramatically and needs exceed treatment availability. This study undertook a comparative assessment of the health and economic return on investment (ROI) of interventions to prevent and treat mental disorders among adolescents (10–19 years) and examined intervention affordability and readiness.

Methods
Interventions were identified following a review of published and grey literature. A Markov model followed a simulated adolescent cohort to estimate implementation costs and health, education, and economic benefits. Intervention affordability was assessed, comparing annual cost per adolescent with NHS England per capita spending, and an expert panel assessed intervention readiness using a validated framework.

Results
Over 10- and 80-year horizons, interventions to treat mild anxiety and mild depression were most cost-effective, with the highest individual lifetime ROI (GBP 5822 GBP 1 and GBP 257: GBP 1). Preventing anxiety and depression was most affordable and ‘implementation ready’ and offered the highest health and economic benefits. A priority package (anxiety and depression prevention; mild anxiety and mild depression treatment) would avert 5 million disability-adjusted life-years (DALYS) and achieve an ROI of GBP 15: GBP 1 over 10 years or 11.5 million DALYs (ROI of GBP 55: GBP 1) over 80 years.

Conclusion
The economic benefits from preventing and treating common adolescent mental disorders equivalent to 25% of NHS England’s annual spending in 2021 over 10 years and 91% over 80 years. Preventing and early treatment for anxiety and depression had the highest ROIs and strong implementation readiness.
Original languageEnglish
Pages (from-to)107-113
Number of pages7
JournalEuropean Journal of Public Health
Volume34
Issue number1
Early online date24 Nov 2023
DOIs
Publication statusPublished - Feb 2024

Keywords

  • anxiety
  • cost-effectiveness
  • adolescent
  • depressive disorders
  • mental health
  • mullerian-inhibiting hormone
  • NHS

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'An investment case analysis for the prevention and treatment of adolescent mental disorders and suicide in England'. Together they form a unique fingerprint.

Cite this